[1]
Dalmau J,Gleichman AJ,Hughes EG,Rossi JE,Peng X,Lai M,Dessain SK,Rosenfeld MR,Balice-Gordon R,Lynch DR, Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. The Lancet. Neurology. 2008 Dec; [PubMed PMID: 18851928]
[2]
Hughes EG,Peng X,Gleichman AJ,Lai M,Zhou L,Tsou R,Parsons TD,Lynch DR,Dalmau J,Balice-Gordon RJ, Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2010 Apr 28; [PubMed PMID: 20427647]
[3]
Armangue T,Spatola M,Vlagea A,Mattozzi S,Cárceles-Cordon M,Martinez-Heras E,Llufriu S,Muchart J,Erro ME,Abraira L,Moris G,Monros-Giménez L,Corral-Corral Í,Montejo C,Toledo M,Bataller L,Secondi G,Ariño H,Martínez-Hernández E,Juan M,Marcos MA,Alsina L,Saiz A,Rosenfeld MR,Graus F,Dalmau J, Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. The Lancet. Neurology. 2018 Sep; [PubMed PMID: 30049614]
[4]
Dalmau J,Armangué T,Planagumà J,Radosevic M,Mannara F,Leypoldt F,Geis C,Lancaster E,Titulaer MJ,Rosenfeld MR,Graus F, An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. The Lancet. Neurology. 2019 Nov; [PubMed PMID: 31326280]
[5]
Gable MS,Sheriff H,Dalmau J,Tilley DH,Glaser CA, The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012 Apr; [PubMed PMID: 22281844]
[6]
van Coevorden-Hameete MH,Titulaer MJ,Schreurs MW,de Graaff E,Sillevis Smitt PA,Hoogenraad CC, Detection and Characterization of Autoantibodies to Neuronal Cell-Surface Antigens in the Central Nervous System. Frontiers in molecular neuroscience. 2016 [PubMed PMID: 27303263]
[7]
Iizuka T,Sakai F,Ide T,Monzen T,Yoshii S,Iigaya M,Suzuki K,Lynch DR,Suzuki N,Hata T,Dalmau J, Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology. 2008 Feb 12; [PubMed PMID: 17898324]
[8]
Titulaer MJ,Höftberger R,Iizuka T,Leypoldt F,McCracken L,Cellucci T,Benson LA,Shu H,Irioka T,Hirano M,Singh G,Cobo Calvo A,Kaida K,Morales PS,Wirtz PW,Yamamoto T,Reindl M,Rosenfeld MR,Graus F,Saiz A,Dalmau J, Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis. Annals of neurology. 2014 Mar; [PubMed PMID: 24700511]
[9]
Iizuka T,Kaneko J,Tominaga N,Someko H,Nakamura M,Ishima D,Kitamura E,Masuda R,Oguni E,Yanagisawa T,Kanazawa N,Dalmau J,Nishiyama K, Association of Progressive Cerebellar Atrophy With Long-term Outcome in Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis. JAMA neurology. 2016 Jun 1; [PubMed PMID: 27111481]
[10]
Lagarde S,Lepine A,Caietta E,Pelletier F,Boucraut J,Chabrol B,Milh M,Guedj E, Cerebral (18)FluoroDeoxy-Glucose Positron Emission Tomography in paediatric anti N-methyl-D-aspartate receptor encephalitis: A case series. Brain [PubMed PMID: 26542469]
[11]
N-Methyl-d-aspartate Receptor Antibody Encephalitis: A Concise Review of the Disorder, Diagnosis, and Management., Staley EM,Jamy R,Phan AQ,Figge DA,Pham HP,, ACS chemical neuroscience, 2018 Aug 31 [PubMed PMID: 30134661]
[12]
Breese EH,Dalmau J,Lennon VA,Apiwattanakul M,Sokol DK, Anti-N-methyl-D-aspartate receptor encephalitis: early treatment is beneficial. Pediatric neurology. 2010 Mar; [PubMed PMID: 20159432]
[13]
Titulaer MJ,McCracken L,Gabilondo I,Armangué T,Glaser C,Iizuka T,Honig LS,Benseler SM,Kawachi I,Martinez-Hernandez E,Aguilar E,Gresa-Arribas N,Ryan-Florance N,Torrents A,Saiz A,Rosenfeld MR,Balice-Gordon R,Graus F,Dalmau J, Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. The Lancet. Neurology. 2013 Feb; [PubMed PMID: 23290630]
[14]
Zhang L,Wu MQ,Hao ZL,Chiang SM,Shuang K,Lin MT,Chi XS,Fang JJ,Zhou D,Li JM, Clinical characteristics, treatments, and outcomes of patients with anti-N-methyl-d-aspartate receptor encephalitis: A systematic review of reported cases. Epilepsy [PubMed PMID: 28109991]
[15]
de Bruijn MAAM,van Sonderen A,van Coevorden-Hameete MH,Bastiaansen AEM,Schreurs MWJ,Rouhl RPW,van Donselaar CA,Majoie MHJM,Neuteboom RF,Sillevis Smitt PAE,Thijs RD,Titulaer MJ, Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA{sub}B{/sub}R encephalitis. Neurology. 2019 May 7; [PubMed PMID: 30979857]
[16]
Wang HY,Li T,Li XL,Zhang XX,Yan ZR,Xu Y, Anti-N-methyl-D-aspartate receptor encephalitis mimics neuroleptic malignant syndrome: case report and literature review. Neuropsychiatric disease and treatment. 2019; [PubMed PMID: 31040676]
[17]
Critical Care Management of Anti-N-Methyl-D-Aspartate Receptor Encephalitis., Neyens RR,Gaskill GE,Chalela JA,, Critical care medicine, 2018 Sep [PubMed PMID: 29927776]
[18]
Balu R,McCracken L,Lancaster E,Graus F,Dalmau J,Titulaer MJ, A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis. Neurology. 2019 Jan 15; [PubMed PMID: 30578370]